| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an improved BRSV vaccine composition, which advantageously provides immunity from infection after a single administration. <P>SOLUTION: There is provided the BRSV vaccine composition comprising a modified live BRS virus and an adjuvant, which, in combination, provide immunity from BRSV infection after a single administration, and elicit an immune response specific to BRSV and including cell-mediated immunity and local (secretory IgA) immunity. <P>COPYRIGHT: (C)2012,JPO&INPIT |
